STING1 and neoplasm: Similarly, the administration of topotecan, an inhibitor of topoisomerase I, in E0771 murine breast cancer cells leads to the release of immunogenic DNA that induced cGAS-STING-dependent signaling, thereby driving anti-tumor immunity [116].